The GAAP revenue decline is structural (contract restructuring) and was expected, but the 1.7% pro-forma growth is below the 6-8% full-year guidance, raising execution risk. Monitor upcoming quarters for acceleration in Patient Services and Wound Care to validate the guidance trajectory. The EPS beat and margin expansion provide near-term support, but the stock may remain range-bound until revenue growth re-accelerates.
Price Chart
Executive Summary
InfuSystem reported Q1 2026 GAAP revenue of $33.7M, down 3% YoY due to the GE Healthcare contract restructuring, but net income improved to $1.0M ($0.05/diluted share) vs a net loss of $0.3M in Q1 2025. Adjusted EBITDA was flat at $6.4M, while margins expanded to 18.9%. The company reaffirmed its full-year 2026 guidance for 6-8% pro-forma revenue growth and mid-to-low 20% Adjusted EBITDA margins. The beat on EPS vs consensus ($0.05 actual vs $0.04 estimate) and maintained guidance are positive, but the GAAP revenue decline tempers the outlook.
Key Financial Metrics
Key Facts
- Q1 2026 net revenues of $33.7M, down 3% YoY from $34.7M
- GAAP net income of $1.0M ($0.05/diluted share) vs net loss of $0.3M ($0.01/diluted share) in Q1 2025
- Adjusted EBITDA (non-GAAP) of $6.4M, essentially flat vs $6.3M in Q1 2025
- Adjusted EBITDA margin expanded to 18.9% from 18.2% in Q1 2025
- Patient Services revenue grew 6% YoY to $22.1M; Device Solutions revenue fell 17% YoY to $11.6M
- Wound Care revenue more than doubled to $2.1M, now 6% of total revenue
- GE Healthcare contract restructuring reduced Q1 revenue by $1.6M; pro-forma revenue growth was 1.7%
- Full-year 2026 guidance reaffirmed: pro-forma net revenue growth of 6-8%, Adjusted EBITDA margin in mid-to-low 20% range
- Stock repurchases totaled $856K in Q1 2026
- Operating cash flow was $1.0M vs $1.8M in Q1 2025
Financial Impact
GAAP revenue decline of 3% YoY ($1.0M reduction) due to contract restructuring; EPS beat of $0.01 vs consensus; Adjusted EBITDA flat at $6.4M
Risk Factors
- Pro-forma revenue growth of 1.7% in Q1 is well below the 6-8% full-year guidance, creating downside risk if growth does not accelerate
- Device Solutions revenue declined 17% YoY, driven by the GE Healthcare restructuring and a large customer rental buyout, which may persist
- Operating cash flow declined to $1.0M from $1.8M in Q1 2025, reflecting higher working capital needs
- ERP system go-live in March 2026 may cause near-term operational disruptions and elevated expenses
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-031649 |
| Document: infu-20260507.htm | 0001628280-26-031649 |
| Document: 0001628280-26-031649-index-headers.html | 0001628280-26-031649 |
| Document: 0001628280-26-031649-index.html | 0001628280-26-031649 |
| Document: 0001628280-26-031649.txt | 0001628280-26-031649 |
| 8-K Data (Synthetic) | 0001628280-26-031649 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $13.75 | awaiting T+5 | — | $14.02 (+2.00%) |
Aug 4, 2026 12w ago | 8-K | $12.32 $12.46 | ▲ +1.14% | ▲ +1.24% | $14.02 (+13.84%) |
Aug 4, 2026 12w ago | 8-K | $12.32 $12.46 | ▲ +1.14% | ▲ +1.24% | $14.02 (+13.84%) |
Jul 28, 2026 13w ago | 8-K | $9.92 $9.22 | ▼ −7.06% | ▼ −9.33% | $14.02 (+41.38%) |
May 18, 2026 23w ago | 8-K | $9.67 $9.45 | ▼ −2.28% | ▼ −4.52% | $14.02 (+45.04%) |
May 14, 2026 23w ago | 8-K | $8.61 $9.94 | ▲ +15.45% | ▲ +16.16% | $14.02 (+62.89%) |
May 12, 2026 23w ago | 8-K | $8.21 $9.67 | ▲ +17.78% | ▲ +18.94% | $14.02 (+70.83%) |
May 8, 2026 24w ago | Insider Cluster | $8.41 $8.61 | ▲ +2.38% | ▲ +0.91% | $14.02 (+66.77%) |
May 8, 2026 24w ago | Insider Cluster | $8.41 $8.61 | ▲ +2.38% | ▲ +0.91% | $14.02 (+66.77%) |
May 7, 2026 24w ago | 8-K | $8.97 $8.21 | ▼ −8.47% | ▼ −9.98% | $14.02 (+56.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers